Xeris Biopharma Holdings Inc (XERS)
3.015
-0.04
(-1.15%)
USD |
NASDAQ |
Nov 15, 09:51
Xeris Biopharma Holdings Cash and Short Term Investments (Quarterly): 69.40M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 69.40M |
| June 30, 2024 | 77.57M |
| March 31, 2024 | 87.35M |
| December 31, 2023 | 72.45M |
| September 30, 2023 | 65.98M |
| June 30, 2023 | 80.67M |
| March 31, 2023 | 95.10M |
| December 31, 2022 | 121.97M |
| September 30, 2022 | 93.43M |
| June 30, 2022 | 111.55M |
| March 31, 2022 | 132.15M |
| December 31, 2021 | 102.43M |
| September 30, 2021 | 92.98M |
| June 30, 2021 | 115.98M |
| Date | Value |
|---|---|
| March 31, 2021 | 135.89M |
| December 31, 2020 | 133.79M |
| September 30, 2020 | 141.74M |
| June 30, 2020 | 144.00M |
| March 31, 2020 | 96.94M |
| December 31, 2019 | 75.55M |
| September 30, 2019 | 102.47M |
| June 30, 2019 | 124.51M |
| March 31, 2019 | 147.67M |
| December 31, 2018 | 112.63M |
| September 30, 2018 | 131.04M |
| June 30, 2018 | 134.53M |
| March 31, 2018 | 58.11M |
| December 31, 2017 | 42.04M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
65.98M
Minimum
Sep 2023
144.00M
Maximum
Jun 2020
102.35M
Average
96.02M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Zevra Therapeutics Inc | 49.26M |
| NovaBay Pharmaceuticals Inc | 0.776M |
| Palatin Technologies Inc | 9.527M |
| iBio Inc | 14.21M |
| Theriva Biologics Inc | 16.59M |